Atlas Trials

Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Clinical trial NCT00893789 · TERMINATED

Trial details

NCT number
NCT00893789
Sponsor
Cephalon, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Traumatic Brain Injury
Start date
2009-04-30
Primary completion
2011-01-31
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.